Skip to main content
S&P 5007,619.98-0.48%DOW52,421.20-0.29%NASDAQ26,186.41-0.56%BTC$77,995.00+1.59%ETH$2,515.85+1.31%GOLD$4,333.30-0.43%OIL$102.74+1.33%
Smart Investors Daily
NS

NASDAQ · NSPR

InspireMD, Inc.

Healthcare · Medical - Devices

$0.79

Up+$0.02 (+2.46%)

Updated Sep 15, 2026, 1:16 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
82.62M
P/E ratio
-3.1
Dividend yield
0.00%
52-week range
$0.63 – $1.98
Volume
31.98K
Avg. volume
128.09K

Price performance

NSPR price history

1M range · 19 trading sessions · Daily adjusted prices

NSPR closed at $0.79 after 19 trading sessions, down 10.22% for the selected period.

Last close
$0.79
Period change
-10.22%
Period low
$0.78
Period high
$0.92
Daily close
View OHLC price history
NSPR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 11, 2026$0.80$0.8099$0.7652$0.789931.98K
Sep 10, 2026$0.80$0.80$0.7529$0.779939K
Sep 9, 2026$0.822$0.8498$0.7628$0.7948.64K
Sep 8, 2026$0.8315$0.8625$0.81$0.830172.38K
Sep 4, 2026$0.835$0.8986$0.825$0.853230.33K
Sep 3, 2026$0.8998$0.8998$0.8376$0.842628.91K
Sep 2, 2026$0.8983$0.90$0.8402$0.840266.12K
Sep 1, 2026$0.8645$0.9085$0.845$0.908545.77K
Aug 31, 2026$0.9046$0.9284$0.867$0.890872.91K
Aug 28, 2026$0.8757$0.8961$0.83$0.8574.28K
Aug 27, 2026$0.9049$0.9498$0.86$0.888723.32K
Aug 26, 2026$0.9027$0.92$0.89$0.8935.21K
Aug 25, 2026$0.85$0.949$0.85$0.920249.94K
Aug 24, 2026$0.875$0.8901$0.86$0.8699113.07K
Aug 21, 2026$0.8906$0.8998$0.85$0.899884.01K
Aug 20, 2026$0.9137$0.92$0.86$0.899946.81K
Aug 19, 2026$0.8571$0.9705$0.8501$0.9099102.6K
Aug 18, 2026$0.8787$0.9272$0.85$0.881674.26K
Aug 17, 2026$0.9476$1.00$0.812$0.8798528.59K

Latest NSPR news

The latest Smart Investors Daily articles mentioning NSPR.

Stock researchCompany · Overview

NSPR research

Overview

Company profile and research snapshot.

Company profile

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$4.75
Implied upside
—
Analysts
8
NSPR recent ratings
DateFirmRatingTarget
May 5, 2026Piper SandlerOverweight—
May 12, 2025Piper SandlerOverweight—
Dec 11, 2024Lake StreetBuy—
Sep 17, 2024Piper SandlerOverweight—
Nov 2, 2023Piper SandlerOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 4, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s Board of Directors approved inducement grants to a new non-executive employee in the aggregate amount of 23,764 shares of restricted stock (the “Inducement Grants”) outside of InspireMD’s 2021 Equity Incentive Plan, with a grant date as of September

Yahoo · Sep 3, 2026

InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By